Colorado Springs, Colo.: USADA announced today that Dmitrii Smoliakov, of Kaliningrad, Russia, has accepted a two-year sanction for a violation of the UFC® Anti-Doping Policy after testing positive for prohibited substances.
Smoliakov, 37, tested positive for recombinant human erythropoietin (rHuEPO) and intact human chorionic gonadtrophin (hCG) as the result of urine samples he provided out-of-competition on April 22, 2019 and in-competition on April 27, 2019 at ESPN+ FN 10, where he lost by technical knockout. rHuEPO is a synthetic hormone used to stimulate the body’s production of red blood cells, thereby increasing oxygen transport and aerobic power, and is prohibited at all times in the class of Peptide Hormones, Growth Factors, Related Substances, and Mimetics under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List. hCG is also in the class Peptide Hormones, Growth Factors, Related Substances and Mimetics and its use is prohibited for males at all times under the UFC Anti-Doping Policy.
Smoliakov’s two-year period of ineligibility, the standard sanction for a non-Specified Substance under the UFC Anti-Doping Policy, began on April 22, 2019, the date his first positive sample was collected. Smoliakov has not competed in the UFC since his fight on April 27, 2019.
Roberto Villa is the CEO, Founder, Executive Writer, Senior Editor of FightBook MMA. Has a passion for Combat Sports and also a podcast host for Sitting Ringside. He’s also a former MMA fighter and Kickboxer.